Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction. The PACMAN-AMI randomized clinical trial.
Effect of alirocumab added to high-intensity statin therapy on coronary atherosclerosis in patients with acute myocardial infarction. The PACMAN-AMI randomized clinical trial.